—
Swiss Re: Advance information on Investor Day without surprises. Pleasing operational progress at Problem Child Corporate Solutions. Courageous guidelines for the coming year. Otherwise statements are very vague and not binding. Share in demand before the trading day. ZKB is for MARKET WEIGHTS.
U-blox: Submits a merger offer to rival Telit. Offers shareholders £ 2.50 per Telit share in treasury stock. Confirms speculation from late Thursday afternoon. Conspicuous warrant purchases shortly before the end of trading. An M&A portal from the island knew more. Kepler Cheuvreux stays with REDUCE up to 45 Fr. ZKB, however, is for OVERWEIGHT.
FIG: JP Morgan is up to CHF 22 (21.50) for UNDERWEIGHT, UBS, however, is up to CHF 28 (27) for BUY. Deutsche Bank contradicts this and goes on SELL (Hold) up to 22 Fr.
Aryzta: Company boss Kevin Toland resigns surprisingly. VR President Urs Jordi (ex-Hiestand) steps in. ZKB is pleased and confirms OVERWEIGHT.
Ascom: Signs a syndicated loan with a Swiss bank. UBS goes to BUY (neutral) up to CHF 16 (12). Until recently, the share was even a SELL for the big bank.
Georg Fischer: Julius Baer is for BUY up to 1200 (1050) Fr. Believes the industry veteran is on target.
Oerlikon: Worldwide demand for protective masks ensures incoming orders in the high double-digit million range.
Richemont: HSBC is for HOLD up to 83 (68) Fr.
Roche: Since Thursday afternoon, major shifts in the direction of the rival Novartis to listen. Covid-19 fantasy at Roche is dampened by vaccine news.
SGS: MainFirst Bank starts with HOLD up to CHF 2,450. Profit recovery after Covid-19 largely priced in.
Sonova: Berenberg Bank stays for HOLD until 215 (210) Fr.
Swatch Group: HSBC goes on HOLD (Buy) to 255 Fr.
Vifor: Mirabaud Securities is up for BUY to 182 (179) Fr. Pharmaceutical manufacturer secures new revenue streams.
Derivate: Occasionally larger sales in the call warrants ASCBJB and ASCJJB Ascom as well as in UBXVJB U-blox.
–
